NCT07041762

Brief Summary

This study compares two nerve block techniques-Rhomboid Intercostal with Sub-Serratus Plane Block versus Erector Spinae Plane Block-for pain relief after breast cancer surgery. It aims to determine which method provides better postoperative pain control, reduces opioid use, and improves recovery in patients undergoing modified radical mastectomy at the National Cancer Institute, Cairo University.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jun 2025Jul 2026

Study Start

First participant enrolled

June 1, 2025

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

June 10, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 27, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

June 27, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

June 10, 2025

Last Update Submit

June 25, 2025

Conditions

Keywords

erector spinae block

Outcome Measures

Primary Outcomes (2)

  • Postoperative Pain Scores

    Postoperative pain will be assessed using the Visual Analog Scale (VAS) both at rest (static) and during movement (dynamic). Assessments will be conducted at 2, 6, 12, and 24 hours following surgery. The VAS is a 10-centimeter scale, where 0 indicates "no pain" and 10 indicates the "worst imaginable pain." Unit of Measure: VAS score (0-10)

    First 24 hours postoperatively

  • Total Opioid Consumption

    The total amount of opioid analgesics administered within the first 24 postoperative hours will be recorded for each patient. All opioid dosages will be converted to intravenous morphine equivalents for standardization. Unit of Measure: Milligrams of intravenous morphine equivalents (mg)

    First 24 hours postoperatively

Study Arms (2)

Rhomboid Intercostal Block with Sub-Serratus Plane Block

EXPERIMENTAL

Participants in this group will receive ultrasound-guided Rhomboid Intercostal Block (20 mL of 0.25% bupivacaine between rhomboid major and intercostal space) followed by Sub-Serratus Plane Block (20 mL of 0.25% bupivacaine between serratus anterior and ribs) 30-45 minutes before general anesthesia for Modified Radical Mastectomy.

Procedure: Rhomboid Intercostal Block with Sub-Serratus Plane Block

Erector Spinae Plane Block

ACTIVE COMPARATOR

Participants in this group will receive an ultrasound-guided Erector Spinae Plane Block with 30 mL of 0.25% bupivacaine injected into the paraspinal plane at the T4-T5 level, 30-45 minutes prior to general anesthesia for Modified Radical Mastectomy.

Procedure: Erector Spinae Plane Block

Interventions

Ultrasound-guided regional anesthesia combining two injections: Rhomboid Intercostal Block (20 mL of 0.25% bupivacaine injected between rhomboid major and intercostal space) Sub-Serratus Plane Block (20 mL of 0.25% bupivacaine injected between serratus anterior and ribs). Both performed 30-45 minutes before Modified Radical Mastectomy under general anesthesia.

Rhomboid Intercostal Block with Sub-Serratus Plane Block

Ultrasound-guided regional block with 30 mL of 0.25% bupivacaine injected into the paraspinal plane at the T4-T5 level, between the erector spinae muscle and the transverse processes. Performed 30-45 minutes prior to general anesthesia for Modified Radical Mastectomy.

Erector Spinae Plane Block

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female breast cancer patients undergoing Modified Radical Mastectomy (MRM)
  • ASA physical status II or III
  • Age between 18 and 65 years
  • Body Mass Index (BMI) \> 20 kg/m² and \< 35 kg/m²

You may not qualify if:

  • Patient refusal
  • ASA physical status IV
  • Age \<18 years or \>65 years
  • BMI \< 20 kg/m² or \> 35 kg/m²
  • Known allergy or contraindication to local anesthetics or opioids
  • History of psychological disorders or chronic pain
  • Contraindications to regional anesthesia (e.g., coagulopathy, local infection, peripheral neuropathy)
  • Severe respiratory, cardiac, hepatic, or renal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cancer Institute - Cairo University

Cairo, Egypt

RECRUITING

Related Links

Study Officials

  • Sayed Mahmoud M Abed, MD

    National Cancer Institute - Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sayed Mahmoud M Abed, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double-blind design: Participants, anesthesia providers, investigators, and outcome assessors will be blinded to group allocation. Group assignments will be concealed using opaque sealed envelopes, and blocks will be performed by anesthesiologists not involved in intraoperative care or postoperative evaluation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: double blind
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

June 10, 2025

First Posted

June 27, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

June 27, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) will not be shared due to institutional policies regarding data confidentiality and privacy. Additionally, there is no established infrastructure for secure data sharing or monitoring of secondary data use at this time.

Locations